Global Organ Preservation Market Size Likely to Expand at a CAGR of 7.2% By 2033

As per the current market research conducted by CMI Team, the global Organ Preservation Market size is expected to record a CAGR of 7.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 306.7 Million. By 2033, the valuation is anticipated to reach USD 573.4 Million.

Organ Preservation Market: Growth Factors and Dynamics

• Increasing Demand for Organ Transplants: The growing prevalence of end-stage organ failure and chronic diseases necessitating organ transplantation is a primary driver for the organ preservation market. As the demand for organs continues to rise globally, there’s a parallel need for effective preservation techniques to enhance organ viability during transportation and storage.

• Advancements in Preservation Technologies: Technological advancements, particularly in machine perfusion techniques like hypothermic and normothermic perfusion, have significantly improved organ preservation outcomes. These methods allow for better preservation of organs compared to traditional static cold storage, leading to increased organ utilization rates and improved transplant outcomes.

• Rising Research Investments and Funding: Increased investments in research and development activities focused on improving organ preservation techniques have contributed to market growth. Governments, academic institutions, and private organizations are allocating significant funds towards research aimed at developing novel preservation solutions, devices, and strategies, thereby driving innovation in the field.

• Expanding Organ Donation Networks: Efforts to expand organ donation networks and improve organ procurement processes have positively impacted the organ preservation market. Initiatives aimed at increasing public awareness about organ donation, optimizing organ allocation systems, and establishing efficient organ procurement organizations (OPOs) have led to a greater availability of donor organs for transplantation, driving the demand for organ preservation solutions.

• Rising Organ Transplantation Rates: The increasing number of successful organ transplantations worldwide, coupled with advancements in surgical techniques and immunosuppressive therapies, has fueled the demand for organ preservation technologies. Organ preservation plays a crucial role in maintaining organ viability during the critical period between procurement and transplantation, thereby supporting the growing number of transplant procedures across different organ types.

• Growing Geriatric Population and Chronic Diseases: The aging population, coupled with the rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and kidney diseases, has led to a higher demand for organ transplantation. Elderly individuals often require transplants due to age-related organ failure, driving the need for effective organ preservation methods that can maintain organ quality and viability, particularly in older donor organs.

Organ Preservation Market: Partnership and Acquisitions

• In 2022, launching the LIVERguard Donor Liver Preservation System in both the US and Europe, Paragonix Technologies expanded its product line and enhanced its market presence, strategically positioning itself to serve a wider customer base across different regions.

• In 2021, Institut Georges Lopez (IGL) expanded its presence by establishing a manufacturing facility in Cheyyar, Tamil Nadu, India. This facility focuses on producing medical devices and solutions for flushing and preserving organs, facilitating the company’s reach and operations in the Indian market.

Report Scope

Organ Preservation Market: COVID-19 Analysis

The COVID-19 pandemic has had a significant impact on the Organ Preservation Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Disruption in Organ Procurement and Transplantation Activities: During the peak of the COVID-19 pandemic, many hospitals and healthcare facilities suspended non-essential surgeries, including organ transplant procedures, to conserve resources and minimize the risk of virus transmission.

• Supply Chain Disruptions and Manufacturing Challenges: The organ preservation market experienced supply chain disruptions and manufacturing challenges due to lockdowns, travel restrictions, and workforce shortages imposed to contain the spread of COVID-19. Delays in the production and distribution of preservation solutions, machines, and related consumables hindered the availability of these critical products, impacting the overall market dynamics.

• Resumption of Elective Surgeries and Organ Transplant Procedures: As the COVID-19 situation improves and healthcare systems stabilize, there will be a gradual resumption of elective surgeries, including organ transplant procedures. Hospitals and transplant centers are likely to prioritize clearing backlogs of transplant cases, leading to a rebound in demand for organ preservation solutions and devices.

• Rapid Adoption of Advanced Preservation Technologies: The COVID-19 pandemic has underscored the importance of advanced organ preservation technologies, such as hypothermic and normothermic machine perfusion, which offer superior outcomes compared to traditional cold storage methods. Post-pandemic, there may be an accelerated adoption of these advanced preservation techniques to optimize organ preservation outcomes and mitigate the impact of future disruptions.

• Increased Focus on Research and Development: The pandemic has highlighted the need for continuous innovation in organ preservation techniques to address emerging challenges and enhance resilience against future crises. There may be heightened investments in research and development initiatives aimed at improving the efficacy, efficiency, and scalability of organ preservation solutions, driving technological advancements and market growth.

• Expansion of Organ Donation Networks and Procurement Infrastructure: Efforts to expand organ donation networks and strengthen organ procurement infrastructure will be crucial for revitalizing the organ preservation market post-COVID-19. Investments in improving organ allocation systems, enhancing coordination among transplant centers and organ procurement organizations, and streamlining procurement processes will help increase the availability of donor organs and boost demand for preservation solutions.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Organ Preservation Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Organ Preservation Market:

• XVIVO Perfusion AB
• TransMedics Inc.
• Organ Recovery Systems Inc.
• Preservation Solutions Inc.
• Bridge to Life Ltd.
• Franz Köhler Chemie GmbH
• Paragonix Technologies Inc.
• BioLife Solutions Inc.
• Waters Medical Systems LLC
• XVIVO Perfusion Inc.
• OrganOx Limited
• Organ Assist B.V.
• Preservation Solutions Inc.
• 21st Century Medicine
• Transplant Biomedicals S.L.
• Others

The Organ Preservation Market is segmented as follows:

By Type

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)
• Others

By Organ

• Kidney
• Liver
• Heart
• Lung
• Others

By Preservation Solution

• Intracellular Solutions
• Extracellular Solutions
• Colloids
• Others

By End User

• Hospitals
• Organ Banks
• Tissue Banks
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America